Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHARLES F LOVELL

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1174629448
CMS profile
325880
Location
NORFOLK, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$2,590.74

45 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 1 of 1; records 1–45 of 45 matching records. This page contains 45 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHARLES F LOVELL

NPI 1174629448 · CMS profile ID 325880

Allopathic & Osteopathic Physicians / Internal Medicine

NORFOLK, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–45 of 45 matching records. This page contains 45 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1174629448?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHARLES F LOVELL, NPI 1174629448, CMS profile ID 325880. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–45 of 45 matching records. This page contains 45 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174629448?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). CHARLES F LOVELL, NPI 1174629448, CMS profile ID 325880. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–45 of 45 matching records. This page contains 45 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174629448?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
CHARLES F LOVELL, NPI 1174629448, CMS profile ID 325880, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–45 of 45 matching records. This page contains 45 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1174629448?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

45 matching records · $2,590.74 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 45 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–45 of 45.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Bayer HealthCare Pharmaceuticals Inc. $15.9211/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789087101 CMS
Novartis Pharmaceuticals Corporation $68.7411/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813038073 CMS
Janssen Pharmaceuticals, Inc $14.6811/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787956763 CMS
AstraZeneca Pharmaceuticals LP $8.8711/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829402621 CMS
Novartis Pharmaceuticals Corporation $292.0011/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813038061 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.8910/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763353576 CMS
Corcept Therapeutics $15.2510/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837517625 CMS
Bayer HealthCare Pharmaceuticals Inc. $11.9210/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789163687 CMS
Amgen Inc. $14.0109/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825212653 CMS
AstraZeneca Pharmaceuticals LP $22.3609/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829394123 CMS
Novartis Pharmaceuticals Corporation $584.0008/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813038065 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.4608/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763353578 CMS
Bayer HealthCare Pharmaceuticals Inc. $15.6108/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789061827 CMS
Novartis Pharmaceuticals Corporation $47.9408/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813038069 CMS
Corcept Therapeutics $15.8608/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837517597 CMS
Janssen Pharmaceuticals, Inc $12.8508/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787956765 CMS
Corcept Therapeutics $15.2508/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837517595 CMS
Amgen Inc. $15.4007/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825212649 CMS
AstraZeneca Pharmaceuticals LP $14.9707/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829747239 CMS
Corcept Therapeutics $15.2507/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837517591 CMS
Janssen Pharmaceuticals, Inc $12.2506/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787956761 CMS
Kowa Pharmaceuticals America, Inc. $12.4706/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 805521721 CMS
Novartis Pharmaceuticals Corporation $876.0006/08/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813038057 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.0806/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763353580 CMS
Vifor Pharma, Inc. $23.3105/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 816110013 CMS
ARBOR PHARMACEUTICALS, INC. $11.6905/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830938037 CMS
Lilly USA, LLC $16.8005/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 860804335 CMS
AstraZeneca Pharmaceuticals LP $16.7505/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829874993 CMS
Amarin Pharma Inc. $17.7504/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815302901 CMS
Lilly USA, LLC $18.9803/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818901059 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.0203/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763353582 CMS
Vifor Pharma, Inc. $15.7503/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 816096295 CMS
AstraZeneca Pharmaceuticals LP $17.2503/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829720591 CMS
Amarin Pharma Inc. $16.3902/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815094393 CMS
Lilly USA, LLC $15.2902/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819007023 CMS
AstraZeneca Pharmaceuticals LP $18.5602/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830109731 CMS
Esperion Therapeutics, Inc. $51.0002/05/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838343761 CMS
Esperion Therapeutics, Inc. $51.0002/05/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838343765 CMS
Amarin Pharma Inc. $20.0102/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815036825 CMS
Lilly USA, LLC $18.7502/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819007019 CMS
AstraZeneca Pharmaceuticals LP $18.0001/28/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829637571 CMS
ARBOR PHARMACEUTICALS, INC. $11.4401/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830937957 CMS
Amarin Pharma Inc. $23.9501/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815036829 CMS
AstraZeneca Pharmaceuticals LP $23.2101/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829701633 CMS
Lilly USA, LLC $19.8101/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819002097 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,516.90 64
PY2020 $2,823.11 39
PY2021 $2,590.74 45
PY2022 $737.64 35
PY2023 $454.03 20
PY2024 $2,529.63 39
PY2025 $681.28 22

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $262,318.22 41
PY2024 Principal investigator $226,779.68 27
PY2023 Principal investigator $241,422.11 79
PY2022 Principal investigator $283,192.02 266
PY2021 Principal investigator $197,651.91 425
PY2020 Principal investigator $248,697.42 325
PY2019 Recipient $12,988.10 1
PY2019 Principal investigator $359,002.06 260

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

266 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $2,467.71 12/31/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
AMETHYST Congestive Heart Failure CHF Heart Failure Therapy Area Cardiovascular, Renal and Metabolism No dispute reported 06/30/2026 914600117
Principal investigator 1 Novo Nordisk AS $2,918.16 12/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896995821
Principal investigator 1 Novo Nordisk AS $1,322.10 12/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 897183117
Principal investigator 1 Novo Nordisk AS $23.06 12/16/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897073277
Principal investigator 1 Novo Nordisk AS $46.12 12/13/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897044457
Principal investigator 1 Novo Nordisk AS $2,001.60 12/02/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896975483
Principal investigator 1 Novo Nordisk AS $1,087.88 11/30/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897250809
Principal investigator 1 ModernaTX, Inc. $2,890.00 11/23/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 963538011
Principal investigator 1 ModernaTX, Inc. $2,918.16 10/26/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 963538007
Principal investigator 1 Novo Nordisk AS $2,156.40 10/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896925187
Principal investigator 1 Novo Nordisk AS $3,478.22 10/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897204925
Principal investigator 1 Novo Nordisk AS $810.00 10/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897249093
Principal investigator 1 VERTEX PHARMACEUTICALS INCORPORATED $20,529.88 10/20/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 18 Years and Older With APOL1-mediated Proteinuric Kidney Disease No dispute reported 06/30/2026 904835461
Principal investigator 1 Novartis Pharmaceuticals Corporation $9,993.00 10/18/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, 20-WEEK DOSE-FINDING STUDY TO EVALUATE EFFICACY, SAFETY, AND TOLERABILITY OF XXB750 IN PATIENTS WITH RESISTANT HYPERTENSION No dispute reported 06/30/2026 909427633
Principal investigator 1 Novo Nordisk AS $4,291.38 09/30/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247949
Principal investigator 1 Novo Nordisk AS $1,761.20 09/28/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897164159
Principal investigator 1 ModernaTX, Inc. $10,203.18 08/29/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 963537979
Principal investigator 1 Novo Nordisk AS $1,089.54 08/26/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135555
Principal investigator 1 Novo Nordisk AS $1,797.19 08/22/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897044467
Principal investigator 1 Novo Nordisk AS $1,322.10 08/22/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 897220887
Principal investigator 1 Novo Nordisk AS $23.06 08/19/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194363
Principal investigator 1 Novo Nordisk AS $23.06 07/28/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897044470
Principal investigator 1 Novo Nordisk AS $661.05 07/27/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896894355
Principal investigator 1 Novo Nordisk AS $637.74 07/27/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203443
Principal investigator 1 Novo Nordisk AS $1,346.63 07/27/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897224226
Principal investigator 1 Novo Nordisk AS $23.06 07/26/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194369
Principal investigator 1 ModernaTX, Inc. $2,209.68 07/13/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 963537969
Principal investigator 1 Novo Nordisk AS $23.06 07/08/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194367
Principal investigator 1 Novo Nordisk AS $70.00 06/30/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896920319
Principal investigator 1 Novo Nordisk AS $661.05 06/30/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896925185
Principal investigator 1 Novo Nordisk AS $3,653.64 06/29/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897089408
Principal investigator 1 Novo Nordisk AS $1,737.28 06/29/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897118519
Principal investigator 1 Novo Nordisk AS $23.06 06/20/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194689
Principal investigator 1 Novo Nordisk AS $67.41 06/16/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897044462
Principal investigator 1 Novo Nordisk AS $46.12 06/14/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194221
Principal investigator 1 ModernaTX, Inc. $12,246.30 06/03/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 963537981
Principal investigator 1 Novo Nordisk AS $70.00 05/31/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896887575
Principal investigator 1 Novo Nordisk AS $1,322.10 05/27/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 897107613
Principal investigator 1 Novo Nordisk AS $1,275.48 05/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203561
Principal investigator 1 Novo Nordisk AS $23.06 05/12/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896894351
Principal investigator 1 Novo Nordisk AS $23.06 05/12/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896920323
Principal investigator 1 Novo Nordisk AS $70.00 04/29/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896927741
Principal investigator 1 Novo Nordisk AS $1,646.64 04/29/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896938261
Principal investigator 1 Novo Nordisk AS $1,893.10 04/29/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897185219
Principal investigator 1 Novo Nordisk AS $2,347.38 04/29/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203557
Principal investigator 1 Novo Nordisk AS $35.00 04/13/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247941
Principal investigator 1 Novo Nordisk AS $75.00 04/13/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247945
Principal investigator 1 Novo Nordisk AS $70.00 03/31/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 897235347
Principal investigator 1 Novo Nordisk AS $4,422.96 03/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896934969
Principal investigator 1 Novo Nordisk AS $23.06 03/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897044477
Principal investigator 1 Novo Nordisk AS $1,087.88 03/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897087943
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896932014
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896932311
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896932315
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896932319
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896932323
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896932463
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896932465
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896932469
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896975527
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896976925
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896977289
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896977343
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896996361
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896996365
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896996371
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896996373
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896996377
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897044393
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897044449
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897044454
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897044473
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897044482
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897055895
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897056699
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897064237
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897064277
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897064281
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897064285
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897064289
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897064301
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897064489
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897073273
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897087931
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897087935
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897087939
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897093087
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897093091
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897093095
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897093285
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897093289
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897108947
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897109261
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897109393
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897109397
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897137215
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897137219
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897137223
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897137272
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897144751
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897144755
Principal investigator 1 Novo Nordisk AS $14.97 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897144771
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897144775
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897144899
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897145003
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194282
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194287
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194289
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194373
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194377
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194381
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194681
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194685
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194693
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194697
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194701
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897194705
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897204921
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897204929
Principal investigator 1 Novo Nordisk AS $11.00 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897204933
Principal investigator 1 Novo Nordisk AS $17.07 03/21/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897204937
Principal investigator 1 Novartis Pharmaceuticals Corporation $30,894.21 03/14/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH
A RANDOMIZED, CONTROLLED, MULTICENTER, OPEN-LABEL TRIAL COMPARING A POST-DISCHARGE CARE PATHWAY INVOLVING AGGRESSIVE LDL-C MANAGEMENT WITH INCLISIRAN WITH USUAL CARE IN PATIENTS WITH A RECENT ACUTE CORONARY SYNDROME No dispute reported 06/30/2026 909424583
Principal investigator 1 ModernaTX, Inc. $1,768.94 03/02/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 963537967
Principal investigator 1 Novo Nordisk AS $1,243.70 03/02/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 896996381
Principal investigator 1 Novo Nordisk AS $70.00 02/28/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 897143483
Principal investigator 1 ModernaTX, Inc. $1,000.00 02/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 963537963
Principal investigator 1 Novo Nordisk AS $2,842.63 02/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896887571
Principal investigator 1 Novo Nordisk AS $1,639.08 02/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896934395
Principal investigator 1 Novo Nordisk AS $25.06 02/18/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897073271
Principal investigator 1 ModernaTX, Inc. $840.40 02/09/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A Phase 3, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 963537961
Principal investigator 1 Novo Nordisk AS $2,371.14 02/09/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897055031
Principal investigator 1 Novo Nordisk AS $2,928.87 02/07/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896919487
Principal investigator 1 Novo Nordisk AS $354.65 02/07/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897093363
Principal investigator 1 Novo Nordisk AS $70.00 01/31/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 897182979
Principal investigator 1 Novo Nordisk AS $25.06 01/27/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897073267
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896854651
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896875683
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896875687
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896892372
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896892377
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896932259
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896933074
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896933078
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896933082
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896934387
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896934973
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896934977
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896939453
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896943207
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896946367
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896975273
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896975481
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896975487
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896975491
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896975495
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896975499
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896975503
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896976877
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896995817
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896995825
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896995829
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897054901
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897055015
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897055019
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897055035
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897055039
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897055043
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897055047
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897055051
Principal investigator 1 Novo Nordisk AS $52.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897055055
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897055715
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897063219
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897063223
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897087227
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897087231
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897087235
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897087239
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897087243
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897087247
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897087251
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897088877
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897088879
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897088883
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897089347
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897089351
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897091357
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897091853
Principal investigator 1 Novo Nordisk AS $25.00 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897091915
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897091919
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897092517
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897092631
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897092635
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897092643
Principal investigator 1 Novo Nordisk AS $73.20 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897092699
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135499
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135503
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135515
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135519
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135523
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135527
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135531
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135535
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135539
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135543
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135547
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135551
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135639
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897135883
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897159497
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897159501
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897159505
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897159509
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897159515
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897159519
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897159521
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897201123
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203427
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203477
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203499
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203517
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203521
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203529
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203533
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203541
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203545
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203549
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203553
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203585
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897203667
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232759
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232761
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232765
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232769
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232781
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232785
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232789
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232793
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232797
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232829
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247769
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247773
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247901
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247905
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247909
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247913
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247917
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247921
Principal investigator 1 Novo Nordisk AS $45.52 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247925
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247929
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247933
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247957
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897248247
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897248997
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897248999
Principal investigator 1 Novo Nordisk AS $22.80 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897249003
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897249011
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897249085
Principal investigator 1 Novo Nordisk AS $19.50 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897249089
Principal investigator 1 Novo Nordisk AS $25.06 01/25/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897271707
Principal investigator 1 Novartis Pharmaceuticals Corporation $43,822.35 01/20/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL, ASSESSING THE IMPACT OF INCLISIRAN ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PARTICIPANTS WITH ESTABLISHED CARDIOVASCULAR DISEASE (VICTORION-2 PREVENT) No dispute reported 06/30/2026 909427641
Principal investigator 1 Novo Nordisk AS $75.00 01/20/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897247937
Principal investigator 1 Novartis Pharmaceuticals Corporation $64,826.76 01/11/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH LLC
A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL ASSESSING THE IMPACT OF LIPOPROTEIN (A) LOWERING WITH TQJ230 ON MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE No dispute reported 06/30/2026 909427649
Principal investigator 1 Novo Nordisk AS $4.27 01/11/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897232719
Principal investigator 1 Novo Nordisk AS $25.06 01/10/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9535-4321 No dispute reported 06/30/2026 897144747
Principal investigator 1 AstraZeneca Pharmaceuticals LP $12,678.51 01/07/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
AMETHYST Congestive Heart Failure CHF Heart Failure Therapy Area Cardiovascular, Renal and Metabolism No dispute reported 06/30/2026 914601997
Principal investigator 1 Novo Nordisk AS $25.06 01/06/2022 Non-covered Recipient Entity
YORK CLINICAL RESEARCH, LLC
NN9924-4635 No dispute reported 06/30/2026 896920315